Aetna to Cut Co-Pays for Heart Patients to Increase Drug Use

Aetna Inc., the third-largest health insurer in the U.S., will cut some co-payments on drugs aimed at preventing heart attacks after a study showed patients took their medicines and were healthier when there were no out-of-pocket costs for their treatments.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.